Natural killer cell proliferation induced by anti-NK1.1 and IL-2

Immunology and Cell Biology

Volumn 76, Issue 2, 1998, Pages 143-152

  Reichlin, Amy ^a,b,c   Yokoyama, Wayne M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Cellular activation; Cellular proliferation; Cytotoxicity; NK cells; NK1.1; NKR P1

Indexed keywords

INTERLEUKIN 2; LYMPHOCYTE SURFACE MARKER;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; IMMUNOMODULATION; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIGENS, LY; ANTIGENS, SURFACE; CELL DIVISION; CELL LINE; CRICETINAE; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MICE; MICE, INBRED C57BL; RATS; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS; TIME FACTORS;

ANIMALIA; MURINAE;

EID: 0031897991     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1998.00726.x     Document Type: Article

References (46)

1. Herberman R. NK Cells and Other Natural Effector Cells. NY: Academic Press, 1982.
2. Trinchieri G. Biology of natural killer cells. Adv. Immunol. 1989; 47: 187-376.
3. Bancroft GJ. The role of natural killer cells in innate resistance to infection. [Review]. Curr. Opin. Immunol. 1993; 5: 503-10.
4. Tripp CS, Wolf SF, Unanue ER. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl Acad. Sci. USA 1993; 90: 3725-9.
5. + cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice. J. Exp. Med. 1993; 178: 1465-72.
6. Locksley RM. Interleukin 12 in host defense against microbial pathogens. Proc. Natl Acad. Sci. USA 1993; 90: 5879-80.
7. Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 1989; 46: 111-41.
8. Timonen T, Ortaldo J, Herberman RB. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J. Exp. Med. 1981, 153: 569-82.
9. Lanier LL, Phillips JH, Hackett J Jr, Tutt M, Kumar V. Natural killer cells: definition of a cell type rather than a function. J. Immunol. 1986; 137: 2735-9.
10. Seaman WE, Sleisenger M, Eriksson E, Koo GC. Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity. J. Immunol. 1987; 138: 4539-44.
11. Sentman CL, Kumar V, Koo G, Bennett M. Effector cell expression of NK 1.1, a murine natural killer cell-specific molecule, and ability of mice to reject bone marrow allografts. J. Immunol. 1989; 142: 1847-53.
12. + cells. J. Immunol. 1986; 136: 3124-31.
13. + T cells. Curr. Opin. Immunol. 1995; 7: 367-74.
14. Biron CA, Van den Elsen P, Tutt MM, Medveczky P, Kumar V, Terhorst C. Murine natural killer cells stimulated in vivo do not express the T cell receptor α, β, γ, T3δ or T3ε genes. J. Immunol. 1987; 139: 1704-10.
15. Ryan JC, Turck J, Niemi EC, Yokoyama WM, Seaman WE. Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules. J. Immunol. 1992; 149: 1631-5.
16. Brown MG, Fulmek S, Matsumoto K et al. A 2 megabase YAC contig and physical map of the natural killer gene complex on mouse chromosome 6. Genomics 1997, 42: 16-25.
17. Chambers WH, Vujanovic NL, DeLeo AB, Olszowy MW, Herberman RB, Hiserodt JC. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J. Exp. Med. 1989; 169: 1373-89.
18. Karlhofer FM, Yokoyama WM. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways. J. Immunol. 1991; 146: 3662-73.
19. Ryan JC, Niemi EC, Goldfien RD, Hiserodt JC, Seaman WE. NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium. J. Immunol. 1991; 147: 3244-50.
20. Ryan JC, Niemi EC, Nakamura MC, Seaman WE. NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity. J. Exp. Med. 1995; 181: 1911-15.
21. Karlhofer FM, Orihuela MM, Yokoyama WM. Ly-49-independent natural killer (NK) cell specificity revealed by NK cell clones derived from p53-deficient mice. J. Exp. Med. 1995; 181: 1785-95.
22. Ortaldo JR, Mason A, Overton R. Lymphokine-activated killer cells. Analysis of progenitors and effectors. J. Exp. Med. 1986; 164: 1193-205.
23. Phillips JH, Lanier LL. Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J. Exp. Med. 1986; 164: 814-25.
24. Stoneman ER, Bennett M, An J et al. Cloning and characterization of 5E6(Ly-49C), a receptor molecule expressed on a subset of murine natural killer cells. J. Exp. Med. 1995; 182: 305-13.
25. Yokoyama WM, Koning F, Kehn PJ et al. Characterization of a cell surface-expressed disulfide-linked dimer involved in murine T cell activation. J. Immunol. 1988; 141: 369-76.
26. Karlhofer FM, Hunziker R, Reichlin A, Margulies DH, Yokoyama WM. Host MHC class I molecules modulate in vivo expression of a NK cell receptor. J. Immunol. 1994; 153: 2407-16.
27. Ziegler SF, Ramsdell F, Alderson MR. The activation antigen CD69. Stem Cells 1994; 12: 456-65.
28. Yokoyama WM, Daniels BF, Seaman WE, Hunziker R, Margulies DH, Smith HR. A family of murine NK cell receptors specific for target cell MHC class I molecules. Semin. Immunol. 1995; 7: 89-101.
29. Biron CA, Turgiss LR, Welsh RM. Increase in NK cell number and turnover rate during acute viral infection. J. Immunol. 1983; 131: 1539-45.
30. McIntyre KW, Welsh RM. Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection. J. Exp. Med. 1988; 164: 1667-81.
31. McIntyre KW, Natuk RJ, Biron CA, Kase K, Greenberger J, Welsh RM. Blastogenesis of large granular lymphocytes in nonlymphoid organs. J. Leukoc. Biol. 1988; 43: 492-501.
32. Tagaya Y, Bamford RN, DeFilippis AP, Waldmann TA. IL-15: A pleiotropic cytokine with diverse receptor signaling pathways whose expression is controlled at multiple levels. Immunity 1996; 4: 329-36.
33. Arase H, Arase N, Saito T. Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. J. Exp. Med. 1996; 183: 2391-6.
34. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 1996; 14: 233-58.
35. Trinchieri G. Interleukin-12 and its role in the generation of Th1 cells. Immunol Today 1993; 14: 335-8.
36. D'Ambrosio D, Hippen KL, Minskoff SA et al. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FcγRIIBI. Science 1995; 268: 293-7.
37. Olcese L, Lang P, Vely F et al. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J. Immunol. 1996; 156: 4531-4.
38. Burshtyn DN, Scharenberg AM, Wagtmann N et al. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 1996; 4: 77-85.
39. Nakamura MC, Niemi EC, Fisher MJ, Shultz LD, Seaman WE, Ryan JC. Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the Shp-1 tyrosine phosphatase. J. Exp. Med. 1997; 185: 673-84.
40. Karlhofer FM, Ribaudo RK, Yokoyama WM. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 1992; 358: 66-70
41. Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 1990; 11: 237-44.
42. de Waal Malefyt R, Yssel H, Roncarolo MG, Spits H, de Vries JE. IL-10. Curr. Opin. Immunol. 1992; 4: 314-20.
43. Lanier LL, Phillips JH. A map of the cell surface antigens expressed on resting and activated human natural killer cells. In: Reinherz EL (ed.) Leukocyte Typing II. New York: Springer-Verlag, 1986; 165-80.
44. + and NK-1.1- inbred mouse strains and their progeny. Cell. Immunol. 1992; 141: 148-60.
45. Moretta A, Bottino C, Pende D et al. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J. Exp. Med. 1990; 172: 1589-98.
46. Patel MR, Lina TJ. Enrichment of mouse splenic natural killer cells using discontinuous polyvinylpyrrolidone silica (Percoll®) gradients. Immunology 1984; 53: 721-9.